drugset / Trial / NCT01626625

Mesenchymal Stem Cells; Donor and Role in Management and Reconstruction of Nonunion Fracture

NCT01626625

Phase 1 Unknown 10 enrolled Indonesia University
Non-randomizedParallel-groupDouble-blindTreatment

Summary

The investigators hypothesized that mesenchymal stem cells can be isolated from fracture site, iliac crest, and tibial crest, and can be expanded to be used in the management of nonunion fracture.

Timeline

Start
2010-04
Primary completion
2015-04
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Rexlemestrocel-L Cell therapy

Indications

No indication recorded.